Abeona Therapeutics (ABEO) EBIT Margin (2011 - 2026)
Abeona Therapeutics (ABEO) reported EBIT Margin of -119.97% for Q2 2026, up 5578.03 percentage points from -5698.00% a year earlier and up 144.17 percentage points from the prior quarter.
Powered by 
Analysis
Abeona Therapeutics (ABEO) EBIT Margin (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Abeona Therapeutics' EBIT Margin came in at -327.64%, up 18306.36 percentage points year-over-year; for FY2025, it came in at -1536.91%.
- EBIT Margin has a five-year change of -722.71 percentage points (FY2020 to FY2025).
- By year, EBIT Margin came in at -1346.71% in FY2023 (+2254.06 pp), -3600.78% in FY2022 (-606.24 pp) and -2994.53% in FY2021 (-2180.33 pp).
- The Q2 2026 figure ranks as the highest quarterly EBIT Margin since Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 28.37% |
| 10 | Abeona Therapeutics | 251.30 Mn | -462.66 Mn | 7.20 Mn | -119.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -119.97% |
| Mar 31, 2026 | -264.14% |
| Dec 31, 2025 | -422.71% |
| Jun 30, 2025 | -5,698.00% |
| Jun 30, 2023 | -301.54% |
| Dec 31, 2022 | -19,023.53% |
| Jun 30, 2022 | -800.80% |
| Mar 31, 2022 | -5,951.16% |
| Dec 31, 2020 | -482.67% |
| Sep 30, 2020 | -89.26% |
| Dec 31, 2018 | -3,736.51% |
| Sep 30, 2018 | -989.82% |
| Jun 30, 2018 | -4,549.64% |
| Mar 31, 2018 | -2,011.86% |
| Dec 31, 2017 | -4,069.77% |
| Sep 30, 2017 | -2,448.40% |
| Jun 30, 2017 | -3,889.40% |
| Mar 31, 2017 | -2,840.86% |
| Dec 31, 2016 | -2,278.13% |
| Sep 30, 2016 | -2,811.96% |
API Access
Abeona Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ABEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ABEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ABEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();